SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $214,000 | -40.2% | 294,480 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $358,000 | +193.4% | 294,480 | 0.0% | 0.00% | – |
| Q4 2018 | $122,000 | -80.9% | 294,480 | -7.8% | 0.00% | -100.0% |
| Q3 2018 | $639,000 | -5.6% | 319,480 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $677,000 | -22.1% | 319,480 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $869,000 | -26.3% | 319,480 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $1,179,000 | +90.2% | 319,480 | 0.0% | 0.00% | +200.0% |
| Q3 2017 | $620,000 | -28.2% | 319,480 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $863,000 | -34.1% | 319,480 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $1,310,000 | -37.0% | 319,480 | -44.4% | 0.00% | -40.0% |
| Q4 2016 | $2,081,000 | +90.6% | 574,999 | +130.0% | 0.01% | +66.7% |
| Q3 2016 | $1,092,000 | – | 249,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |